They will present their research at a Women Chemists Committee (WCC)/Merck half-day symposium and be recognized at the Awards Symposium Luncheon and the WCC Luncheon. Individuals* in their third and ...

AIDDISON is Merck’s AI-powered drug discovery platform that integrates AI-powered molecule design, synthesis planning and direct sourcing of chemical building blocks to accelerate the journey ...

M Chemical, a chemical subsidiary of Merck Korea, has been fully integrated into the German life science and electronics company's semiconductor entity. Starting from Monday, M Chemical is under ...

The Merck Index Online is an encyclopaedic database of chemical substances – an evolution of the printed reference work The Merck Index. While the content has a focus on chemicals and biologicals of ...

ACS award for creative work in synthetic organic chemistry In cooperation with the American Chemical Society (ACS), Merck has sought to honour scientists for outstanding work in the field of ...

Merck (NYSE: MRK) is a top pharmaceutical company coming off a good quarter that shows it is growing its top and bottom lines. Even with that growth, the stock still trades at a fairly modest ...

The Department of Chemical and Biological Engineering at Northwestern University is pioneering transformational discoveries in synthetic biology, biotechnology, catalysis, medicine, complex systems, ...

Merck lowered 2024 EPS guidance down to $7.94 to $8.03, from its previous guidance of $8.53 to $8.65. The new guidance reflects the negative impact of a one-time charge of $1.3 billion or 51 cents ...

Merck & Co., Inc. is a health care company, which engages in the provision of health solutions through its prescription medicines, vaccines, biologic therapies, animal health, and consumer care ...

KMG Chemicals, Inc. manufactures, formulates and globally distributes specialty chemicals. The Company has acquired and operates businesses selling electronic chemicals, industrial wood ...

Merck & Co.’s best-selling drug Keytruda helped women with a hard-to-treat form of breast cancer live longer, according to the first study to show such a benefit in these patients. After five ...